Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29967 | 0.96 | — | — | |
| Tetraoxane SCHEMBL3273646 | 0.92 | TTR (0.36) | TTR | |
| Water SCHEMBL9442576 | 0.92 | TTR (0.36) | TTR | |
| SCHEMBL17180694 | 0.92 | — | — | |
| Cyclooctane SCHEMBL1576491 | 0.89 | TTR (0.33) | TTR | |
| SCHEMBL3741249 | 0.81 | ALDH1A1 (0.47) | TTR | |
| Cyclopentene SCHEMBL7624239 | 0.76 | — | — | |
| Ether SCHEMBL9442575 | 0.74 | — | — | |
| SCHEMBL1484296 | 0.74 | — | — | |
| SCHEMBL8994603 | 0.74 | ALDH1A1 (0.47) | TTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006016903-A2 | 1, 2,4-TRIOXANES AND 1, 2, 4-TRIOXEPANES | ROMARK LABORATORIES, L.C. (US) | 2006-02-16 | — | — | WO | claimed |
| US-20050256184-A1 | 1,2,4-Trioxanes and 1,2,4-trioxepanes | O'NEILL PAUL M | 2005-11-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050256184-A1 | 1,2,4-Trioxanes and 1,2,4-trioxepanes | TALDO1, THPO, ALOX12 | TTR 986/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.